[
  {
    "ts": "2025-12-15T04:40:40+00:00",
    "headline": "3 Cash-Burning Stocks We Steer Clear Of",
    "summary": "Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable.",
    "url": "https://finance.yahoo.com/news/3-cash-burning-stocks-steer-044040792.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "5037f70e-6757-31c9-922b-88cf5e2cb855",
      "content": {
        "id": "5037f70e-6757-31c9-922b-88cf5e2cb855",
        "contentType": "STORY",
        "title": "3 Cash-Burning Stocks We Steer Clear Of",
        "description": "",
        "summary": "Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable.",
        "pubDate": "2025-12-15T04:40:40Z",
        "displayTime": "2025-12-15T04:40:40Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/230fabd0bfcf9e77c094ea9be44ac9a7",
          "originalWidth": 2400,
          "originalHeight": 1352,
          "caption": "UPST Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4BiEZCNapCZCuYY3mV.YqA--~B/aD0xMzUyO3c9MjQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/stockstory_922/230fabd0bfcf9e77c094ea9be44ac9a7.cf.webp",
              "width": 2400,
              "height": 1352,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rDrjOPX24urRuLmE9kM5.Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/230fabd0bfcf9e77c094ea9be44ac9a7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-cash-burning-stocks-steer-044040792.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-cash-burning-stocks-steer-044040792.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "PRPL"
            },
            {
              "symbol": "UPST"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-15T12:00:00+00:00",
    "headline": "EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA)",
    "summary": "mNEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and mRESVIA (Respiratory Syncytial Virus Vaccine) mNEXSPIKE will be available in the European Union, subject to authorization by the ...",
    "url": "https://finance.yahoo.com/news/ema-committee-medicinal-products-human-120000164.html",
    "source": "ACCESS Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "1d91e0fb-2cdc-3cc0-91c1-49c1cb60ce51",
      "content": {
        "id": "1d91e0fb-2cdc-3cc0-91c1-49c1cb60ce51",
        "contentType": "STORY",
        "title": "EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA)",
        "description": "",
        "summary": "mNEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and mRESVIA (Respiratory Syncytial Virus Vaccine) mNEXSPIKE will be available in the European Union, subject to authorization by the ...",
        "pubDate": "2025-12-15T12:00:00Z",
        "displayTime": "2025-12-15T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/accesswire.ca/2233b456baebcb9b5dcb57d6eaa868ac",
          "originalWidth": 400,
          "originalHeight": 400,
          "caption": "<![CDATA[mNEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and mRESVIA ...]]>",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Y14NrymWnVHtLPxT5mPm5g--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/2233b456baebcb9b5dcb57d6eaa868ac.cf.webp",
              "width": 400,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dSewxxG3XkMHQTa3gmVr6w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/2233b456baebcb9b5dcb57d6eaa868ac.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "ACCESS Newswire",
          "url": "https://www.accessnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ema-committee-medicinal-products-human-120000164.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ema-committee-medicinal-products-human-120000164.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-15T14:05:00+00:00",
    "headline": "Amazon and 9 More Stocks to Buy for 2026",
    "summary": "Barron’s capitalized on the trends with  Alibaba Group Holding Alphabet  and  ASML Holding  as well as other winners, including  Citigroup  and  Uber Technologies  in our top 10 picks for 2025.  Rounding out the list is pharmaceutical turnaround candidate  Bristol Myers Squibb  which yields almost 5%.",
    "url": "https://www.barrons.com/articles/best-stocks-buy-2026-amazon-exxon-disney-439f8e78?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "f7313ec6-88e5-3810-9879-cc047e9b1cae",
      "content": {
        "id": "f7313ec6-88e5-3810-9879-cc047e9b1cae",
        "contentType": "STORY",
        "title": "Amazon and 9 More Stocks to Buy for 2026",
        "description": "",
        "summary": "Barron’s capitalized on the trends with  Alibaba Group Holding Alphabet  and  ASML Holding  as well as other winners, including  Citigroup  and  Uber Technologies  in our top 10 picks for 2025.  Rounding out the list is pharmaceutical turnaround candidate  Bristol Myers Squibb  which yields almost 5%.",
        "pubDate": "2025-12-15T14:05:00Z",
        "displayTime": "2025-12-15T14:05:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/f7313ec6-88e5-3810-9879-cc047e9b1cae/amazon-and-9-more-stocks-to.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/5f06a92dafb17f9efa6bfddaecc47bff",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IwI.olz5oM1.OetZkPwp9g--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/5f06a92dafb17f9efa6bfddaecc47bff.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Bz2srNmewET3nyBRDo.jKg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/5f06a92dafb17f9efa6bfddaecc47bff.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/best-stocks-buy-2026-amazon-exxon-disney-439f8e78?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WBD"
            },
            {
              "symbol": "C"
            },
            {
              "symbol": "UBER"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "BABA"
            },
            {
              "symbol": "ASML"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]